Literature DB >> 17306667

Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies.

Jaime M Shamonki1, Jane E Salmon, Elizabeth Hyjek, Rebecca N Baergen.   

Abstract

OBJECTIVE: Studies that use a murine model of antiphospholipid syndrome have demonstrated a critical role for complement activation that leads to fetal and placental injury in the presence of antiphospholipid antibodies (APAs). We examined the placentas of patients with APAs to demonstrate a similar association with tissue injury in humans. STUDY
DESIGN: Immunohistochemical analyses with the use of antibodies to the complement products C4d, C3b, and C5b-9 were performed on paraffin-embedded tissue sections of placentas from 47 patients with APAs and 23 normal control patients.
RESULTS: We found evidence of increased complement deposition in the trophoblast cytoplasm (C4d and C3b), trophoblastic cell and basement membrane (C4d), and extravillous trophoblasts (C4d) of patients with APAs, compared with control patients. We report a correlation between placental pathologic features and complement deposition (C4d) in the trophoblastic cytoplasm, cell membrane, and basement membrane.
CONCLUSION: These findings are consistent with murine studies that implicate complement as a critical factor in the fetal tissue injury observed in antiphospholipid syndrome.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17306667      PMCID: PMC2248299          DOI: 10.1016/j.ajog.2006.10.879

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  24 in total

1.  Inhibition of complement-mediated haemolysis in paroxysmal nocturnal haemoglobinuria by heparin or low-molecular weight heparin.

Authors:  H Ninomiya; Y Kawashima; T Nagasawa
Journal:  Br J Haematol       Date:  2000-06       Impact factor: 6.998

Review 2.  The antiphospholipid syndrome.

Authors:  Jerrold S Levine; D Ware Branch; Joyce Rauch
Journal:  N Engl J Med       Date:  2002-03-07       Impact factor: 91.245

Review 3.  Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis.

Authors:  J E Salmon; G Girardi; V M Holers
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

Review 4.  Management of the obstetric antiphospholipid syndrome.

Authors:  Ronald H W M Derksen; Munther A Khamashta; D Ware Branch
Journal:  Arthritis Rheum       Date:  2004-04

5.  Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss.

Authors:  D W Branch; D J Dudley; M D Mitchell; K A Creighton; T M Abbott; E H Hammond; R A Daynes
Journal:  Am J Obstet Gynecol       Date:  1990-07       Impact factor: 8.661

6.  A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice.

Authors:  Joshua M Thurman; Damian M Kraus; Guillermina Girardi; Dennis Hourcade; Hee J Kang; Pamela A Royer; Lynne M Mitchell; Patricia C Giclas; Jane Salmon; Gary Gilkeson; V Michael Holers
Journal:  Mol Immunol       Date:  2005-01       Impact factor: 4.407

7.  Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome.

Authors:  Guillermina Girardi; Jessica Berman; Patricia Redecha; Lynn Spruce; Joshua M Thurman; Damian Kraus; Travis J Hollmann; Paolo Casali; Michael C Caroll; Rick A Wetsel; John D Lambris; V Michael Holers; Jane E Salmon
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

8.  Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Peter Hillmen; Claire Hall; Judith C W Marsh; Modupe Elebute; Michael P Bombara; Beth E Petro; Matthew J Cullen; Stephen J Richards; Scott A Rollins; Christopher F Mojcik; Russell P Rother
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

Review 9.  Placental adaptive responses and fetal programming.

Authors:  Leslie Myatt
Journal:  J Physiol       Date:  2006-02-09       Impact factor: 5.182

10.  Structural determinants of the capacity of heparin to inhibit the formation of the human amplification C3 convertase.

Authors:  M D Kazatchkine; D T Fearon; D D Metcalfe; R D Rosenberg; K F Austen
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

View more
  46 in total

1.  Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus.

Authors:  Jill P Buyon; Mimi Y Kim; Marta M Guerra; Sifan Lu; Emily Reeves; Michelle Petri; Carl A Laskin; Michael D Lockshin; Lisa R Sammaritano; D Ware Branch; T Flint Porter; Allen Sawitzke; Joan T Merrill; Mary D Stephenson; Elisabeth Cohn; Jane E Salmon
Journal:  Clin J Am Soc Nephrol       Date:  2017-04-11       Impact factor: 8.237

Review 2.  The role of complement in the antiphospholipid syndrome-associated pathology.

Authors:  Ingrid Avalos; George C Tsokos
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

3.  Antiphospholipid antibodies in women with severe preeclampsia and placental insufficiency: a case-control study.

Authors:  K J Gibbins; A E Tebo; S K Nielsen; D W Branch
Journal:  Lupus       Date:  2018-07-20       Impact factor: 2.911

Review 4.  Emerging Treatment Models in Rheumatology: Antiphospholipid Syndrome and Pregnancy: Pathogenesis to Translation.

Authors:  Vikki M Abrahams; Lawrence W Chamley; Jane E Salmon
Journal:  Arthritis Rheumatol       Date:  2017-07-18       Impact factor: 10.995

5.  Placental C4d deposition is a feature of defective placentation: observations in cases of preeclampsia and miscarriage.

Authors:  Eun Na Kim; Bo Hyun Yoon; Joong Yeup Lee; Doyeong Hwang; Ki Chul Kim; JoonHo Lee; Jae-Yoon Shim; Chong Jai Kim
Journal:  Virchows Arch       Date:  2015-03-28       Impact factor: 4.064

Review 6.  Neonatal effects of maternal antiphospholipid syndrome.

Authors:  Angela Tincani; Chiara Biasini Rebaioli; Laura Andreoli; Andrea Lojacono; Mario Motta
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

7.  Spontaneous abortion is associated with elevated systemic C5a and reduced mRNA of complement inhibitory proteins in placenta.

Authors:  M Banadakoppa; M S Chauhan; D Havemann; M Balakrishnan; J S Dominic; C Yallampalli
Journal:  Clin Exp Immunol       Date:  2014-09       Impact factor: 4.330

8.  Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies.

Authors:  Mimi Y Kim; Marta M Guerra; Elianna Kaplowitz; Carl A Laskin; Michelle Petri; D Ware Branch; Michael D Lockshin; Lisa R Sammaritano; Joan T Merrill; T Flint Porter; Allen Sawitzke; Anne M Lynch; Jill P Buyon; Jane E Salmon
Journal:  Ann Rheum Dis       Date:  2018-01-25       Impact factor: 19.103

9.  The C5b-9 membrane attack complex of complement activation localizes to villous trophoblast injury in vivo and modulates human trophoblast function in vitro.

Authors:  R Rampersad; A Barton; Y Sadovsky; D M Nelson
Journal:  Placenta       Date:  2008-09-09       Impact factor: 3.481

Review 10.  Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review.

Authors:  Amelia Ruffatti; Ariela Hoxha; Maria Favaro; Marta Tonello; Anna Colpo; Umberto Cucchini; Alessandra Banzato; Vittorio Pengo
Journal:  Clin Rev Allergy Immunol       Date:  2017-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.